Immunotherapy Drugs Expand Treatment Options for Advanced Lung Cancer

Results from a large clinical trial show combining an immune checkpoint inhibitor with chemotherapy helped some patients with advanced lung cancer live longer than chemotherapy alone. How will this change the lung cancer treatment landscape?

Cancer Currents: An NCI Cancer Research Blog